-
Most Recent
Search Results
240 results for frx
41 S&P 500 Stocks Hit New Lows in Early Tuesday Trading
S&P 500 dips slightly Tuesday, with Urban Outfitters, Abercrombie & Fitch and Citigroup among losers by midday.
MRK: Merck Sells Consumer Business to Double Down on Blockbusters
Swinging for the fences, MRK sold one of the industry’s crown jewels in exchange for an opportunity to find new blockbuster drugs. It’s a risky…
Is Big Pharma Resistant to Antibiotics?
Less profitable drugs take a backseat despite health risks
Actavis Prescribes Profits via M&A and Generic Drugs
This specialty pharmaceutical company is consolidating its way into becoming a post-Affordable Care Act powerhouse.
No Payday In Sight for Alzheimer’s Drug Stocks
At best, the drugs on the market are stopgap measures. They can’t cure the disease.
Is it Time to Follow Ichan Out of Amgen — and Other Biotechs?
Investor Carl Ichan recently dumped several biotechs. However, Amgen’s sales are strong, and with other positives, it’s possible he cut bait too soon.
Johnson & Johnson, Forest Labs Will Make You Sick
Johnson & Johnson beat expectations but its profits were down; Forest Labs missed and has a plunging profit forecast. Investors should be wary of both…
2 Biotech Stocks to Buy After Earnings
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.
SpaceX Created the Chaos. Louis Found the Opportunity.
Louis Navellier has been watching the SpaceX IPO closely — but not because he’s tempted to buy it. What he finds fascinating is how markets…
Wall Street’s 10 Biggest Deals of Q1 2014
The year is off to a hot start for M&A, as Facebook, Google, IBM and others got busy pulling off Q1’s biggest deals.
3 Mutual Funds Poised to Profit From Obamacare
By Bill Wysor — There are winners and losers in the changing healthcare industry, but let seasoned mutual fund managers do the legwork for you.
Buy Icahn Enterprises to Play Apple Stock with Less Risk
For a low-risk way to play a bounce back in Apple stock, let Carl Icahn and a bet on Icahn Enterprises stock lead the way.
4 Best Mutual Funds at Vanguard Now
Here are four of the top mutual fund investments from Vanguard now.
3 Investment Ideas With Room to Run
Luke Lango highlights AI’s toll roads… Brian Hunt flags Brazil’s overlooked AI angle… Louis Navellier’s refiner play amid Mideast turmoil…
The Crowd Found Micron – This Is How to Find the Next One
AI-powered trading tools could soon push millions of investors into the same crowded stocks at the same time. And when that happens, institutional investors may…
The Iranian Ceasefire Collapses: What Happens Now?
The Middle East ceasefire breaks down… Luke Lango says corrections are a feature, not a bug… his gameplan for where to buy… a contrarian 14%…
Celebrity SPAC Merger News: 10 Stars Jumping on the SPAC Bandwagon
Investors should follow the latest celebrity SPAC merger news to see where money is moving. Here’s some of the top stars in the game.
Will 2014’s Top Performers Keep Performing?
These three stocks are likely to run higher, given both valuation and business environment.
What To Make Of Tuesday’s Surprising Market Move
Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here’s our new research on 50 stocks in Portfolio…
Maintain Realistic Expectations
The most that can be expected is a small rally and more sideways movement.
3 Funds to Play the Healthcare Megatrend
Healthcare has been hot in 2013, but more importantly, it’s set up to be a huge mover going forward thanks to several big trends. Here’s…
Micron’s 16 Contracts Reveal the Next AI Bottleneck
Customers are reserving AI memory years in advance. Micron’s contracts may change how investors value memory stocks.
One Mag 7 Killer Hiding in Plain Sight
Since the early AI revolution, the Magnificent Seven companies have been sat securely on the throne. But their seat is soon to be usurped. We are starting to see a rotation out of some of the highest profile,…
7 – 10 of 240 results
